NDC 58829-303 - Furosemide 1%
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 58829-303
- Package NDCs from labels
- 58829-303-60
- Manufacturer
- FIRST PRIORITY INCORPORATED
- Effective date
- 2023-11-02
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Furosemide 1% - FIRST PRIORITY INCORPORATED | FIRST PRIORITY INCORPORATED | 2023-11-02 | PRESCRIPTION ANIMAL DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 58829-303-60 | Furosemide1% | 12 in 1 CASE | SYRUP | 12 | 6 | |
| 58829-303-60 | Furosemide1% | 1 in 1 CARTON | SYRUP | 1 | 6 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| FUROSEMIDE | ACTIVE INGREDIENT | 7LXU5N7ZO5 | FUROSEMIDE 1% (FUROSEMIDE) SYRUP [FIRST PRIORITY INCORPORATED] | 3 | |
| FUROSEMIDE | ACTIVE MOIETY | 7LXU5N7ZO5 | FUROSEMIDE 1% (FUROSEMIDE) SYRUP [FIRST PRIORITY INCORPORATED] | 3 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Furosemide | FUROSEMIDE | Northwind Health Company, LLC | f2b920b2-f8b3-1e6e-e053-2a95a90ae153 | 2026-01-01 | Warnings, Adverse reactions | 7LXU5N7ZO5 |
| Furosemide | FUROSEMIDE | Northwind Health Company, LLC | f3173c0d-2b62-7c7b-e053-2995a90ada05 | 2026-01-01 | Warnings, Adverse reactions | 7LXU5N7ZO5 |
| Furosemide | FUROSEMIDE | Redpharm Drug | 3745be12-ea1d-f450-e063-6294a90a148c | 2025-12-24 | Warnings, Adverse reactions | 7LXU5N7ZO5 |
| Furosemide | FUROSEMIDE | ProPharma Distribution | 38550de1-f099-0cdf-e063-6294a90a9e26 | 2025-12-18 | Boxed warning, Warnings, Adverse reactions | 7LXU5N7ZO5 |
| Furosemide | FUROSEMIDE | A-S Medication Solutions | 54a33042-a163-4f93-96cc-fbd93030e014 | 2025-12-05 | Warnings, Adverse reactions | 7LXU5N7ZO5 |
| Furosemide | FUROSEMIDE | A-S Medication Solutions | 6864b3f6-c5ad-4588-ad04-5260258c6d8c | 2025-12-05 | Warnings, Adverse reactions | 7LXU5N7ZO5 |
| Furosemide | FUROSEMIDE | QPharma Inc | 341e29d9-a6f1-4c77-ae44-9b2c423ea6b4 | 2025-12-03 | Warnings, Adverse reactions | 7LXU5N7ZO5 |
| LASIX ONYU | FUROSEMIDE | SQ Innovation, Inc. | cb27654f-c7a1-4796-ab08-60a5fa16f5c0 | 2025-11-14 | Warnings, Adverse reactions | 7LXU5N7ZO5 |
| FUROSEMIDE | FUROSEMIDE | Civica, Inc. | 7ecaa5af-d186-4380-b105-e7e528f75cc7 | 2025-11-12 | Boxed warning, Warnings, Adverse reactions | 7LXU5N7ZO5 |
| Furosemide | FUROSEMIDE | Eugia US LLC | 421aa6d5-623b-4dc2-abd5-bb9e7765bf37 | 2025-11-11 | Boxed warning, Warnings, Adverse reactions | 7LXU5N7ZO5 |
| Furosemide | FUROSEMIDE | ProPharma Distribution | 43053bf7-9050-dba8-e063-6294a90a7174 | 2025-11-07 | Boxed warning, Warnings, Adverse reactions | 7LXU5N7ZO5 |
| Furosemide | FUROSEMIDE | Hikma Pharmaceuticals USA Inc. | 9e493331-dddd-496e-abf8-61747fb67aba | 2025-11-03 | Warnings, Adverse reactions | 197730 7LXU5N7ZO5 |
| Furosemide | FUROSEMIDE | Civica, Inc. | 6d9caaab-d874-4cf1-b9fe-408452a18998 | 2025-10-31 | Warnings, Adverse reactions | 7LXU5N7ZO5 |
| FUROSEMIDE | FUROSEMIDE | Henry Schein, Inc. | a9853417-0442-4f53-9543-e0749bc3c80d | 2025-10-31 | Boxed warning, Warnings, Adverse reactions | 7LXU5N7ZO5 |
| Furosemide | FUROSEMIDE | Henry Schein, Inc. | d8407b0e-7838-4ab6-b9dd-1f7ecf1e0a17 | 2025-10-31 | Boxed warning, Warnings, Adverse reactions | 7LXU5N7ZO5 |
| FUROSEMIDE | FUROSEMIDE | Henry Schein, Inc. | 15e4c3a3-7d64-471e-bfdf-6156731e24aa | 2025-10-31 | Boxed warning, Warnings, Adverse reactions | 7LXU5N7ZO5 |
| Furosemide | FUROSEMIDE | Medical Purchasing Solutions, LLC. | 4227fab8-a64a-1c9e-e063-6294a90a0682 | 2025-10-27 | Warnings, Adverse reactions | 7LXU5N7ZO5 |
| Furosemide | FUROSEMIDE | PD-Rx Pharmaceuticals, Inc. | 7842eeab-decf-47e7-9134-0add90549a3d | 2025-10-16 | Warnings, Adverse reactions | 7LXU5N7ZO5 |
| Furosemide | FUROSEMIDE | PD-Rx Pharmaceuticals, Inc. | e20257f6-7cfe-43fa-a672-cc1cb312b83a | 2025-10-16 | Warnings, Adverse reactions | 7LXU5N7ZO5 |
| Furosemide | FUROSEMIDE | NuCare Pharmaceuticals, Inc. | 20eecc36-dfb7-0060-e063-6394a90a9d0b | 2025-10-16 | Warnings, Adverse reactions | 7LXU5N7ZO5 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.